Recurrent alterations have been identified in FRA3B and FRA16D in several cancer types, leading to further investigation of the FHIT and WWOX genes, respectively, in mouse models (see K. Huebner and R. Aqeilan chapters in this issue). This evidence concerns the gene FHIT and cancer.